anwerina Deutschland

Anwerina is a German biotechnology company focused on the discovery and development of novel therapeutic agents targeting G protein-coupled receptors (GPCRs). The company leverages its expertise in medicinal chemistry and molecular biology to address unmet medical needs in areas such as inflammation, metabolic disorders, and oncology. Anwerina's research programs are primarily in the pre-clinical stage, aiming to identify high-affinity ligands with optimized pharmacological profiles. By focusing on challenging GPCR targets, the company seeks to develop first-in-class or best-in-class small molecule and peptide-based therapies.